Edge Therapeutics’ CEO Brian Leuthner receives EY Entrepreneur of the Year Award
Brian A. Leuthner, Edge Therapeutics’ CEO, president and co-founder, has received the EY Entrepreneur of the Year 2015 New Jersey Region Award in the Pharmaceutical & Diagnostic Private Companies category. He was selected by an independent judging panel comprising previous winners of the award, CEOs, private capital investors and other regional business leaders.
According to EY, a global provider of assurance, tax, transaction and advisory services, and a division of Ernst & Young, the EY Entrepreneur of the Year award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.
As a New Jersey Region award winner, Leuthner now is eligible for consideration for the EY Entrepreneur of the Year 2015 National Award. Award winners in several national categories, as well as the overall EY Entrepreneur of the Year National Award winner, will be announced at the national awards gala in Palm Springs, Calif., in November 2015.
Leuthner co-founded Edge along with R. Loch Macdonald, the company’s chief scientific officer, and Carl J. Soranno in 2009. Leuthner also sits on the company’s board of directors and has more than 25 years of experience in the hospital acute care marketplace, with specific experience in critical care and neurocritical care.
Previously, Leuthner was the CEO of Fontus Pharmaceuticals, the senior head of marketing for The Medicines Company and the director of Market Development for ESP Pharma. He also held marketing and sales positions of significant responsibility at Burroughs Wellcome, GlaxoWellcome and Ortho Biotech.